Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Orally Disintegrating Tablet Market Insights, Forecast to 2027

Published by QYResearch Product code 998950
Published Content info 132 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Orally Disintegrating Tablet Market Insights, Forecast to 2027
Published: April 8, 2021 Content info: 132 Pages
Description

Market Analysis and Insights: Global Orally Disintegrating Tablet Market

The global Orally Disintegrating Tablet market was valued at US$ 12388 million in 2020 and it is expected to reach US$ 27000 million by the end of 2027, growing at a CAGR of 11.71% during 2021-2027.

Global Orally Disintegrating Tablet Scope and Segment

Orally Disintegrating Tablet market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Orally Disintegrating Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

By Company

  • Teva
  • Merck
  • Mylan
  • Pfizer
  • Johnson and Johnson
  • GSK
  • Otsuka
  • Eli Lilly and Company
  • AstraZeneca
  • Bristol-Myers Squibb
  • Conquer

Segment by Type

  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Other

Segment by Application

  • CNS Diseases
  • Gastrointestinal Diseases
  • CVS Diseases
  • Others

By Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Southeast Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • South America
  • Brazil
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Table of Contents

TABLE OF CONTENTS

1 STUDY COVERAGE

  • 1.1 Orally Disintegrating Tablet Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Orally Disintegrating Tablet Market Size Growth Rate by Type
    • 1.2.2 Anti-Psychotics Drug
    • 1.2.3 Anti-Epileptics Drug
  • 1.3 Market by Application
    • 1.3.1 Global Orally Disintegrating Tablet Market Size Growth Rate by Application
    • 1.3.2 CNS Diseases
    • 1.3.3 Gastrointestinal Diseases
    • 1.3.4 CVS Diseases
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Global Orally Disintegrating Tablet Market Size Estimates and Forecasts
    • 2.1.1 Global Orally Disintegrating Tablet Revenue 2016-2027
    • 2.1.2 Global Orally Disintegrating Tablet Sales 2016-2027
  • 2.2 Orally Disintegrating Tablet Market Size by Region: 2020 Versus 2027
    • 2.2.1 Global Orally Disintegrating Tablet Retrospective Market Scenario in Sales by Region: 2016-2020
    • 2.2.2 Global Orally Disintegrating Tablet Retrospective Market Scenario in Revenue by Region: 2016-2020

3 GLOBAL ORALLY DISINTEGRATING TABLET COMPETITOR LANDSCAPE BY PLAYERS

  • 3.1 Global Top Orally Disintegrating Tablet Manufacturers by Sales
    • 3.1.1 Global Orally Disintegrating Tablet Sales by Manufacturer (2019-2021)
    • 3.1.2 Global Orally Disintegrating Tablet Sales Market Share by Manufacturer (2016-2019)
  • 3.2 Global Top Orally Disintegrating Tablet Manufacturers by Revenue
    • 3.2.1 Global Orally Disintegrating Tablet Revenue by Manufacturer (2019-2021)
    • 3.2.2 Key Orally Disintegrating Tablet Manufacturers Covered: Ranking by Revenue
    • 3.2.3 Global Orally Disintegrating Tablet Revenue Share by Manufacturer (2019-2021)
    • 3.2.4 Global Orally Disintegrating Tablet Market Concentration Ratio (CR5 and HHI) (2019-2021)
    • 3.2.5 Global Top 6 Companies by Orally Disintegrating Tablet Revenue in 2020
    • 3.2.6 Global Orally Disintegrating Tablet by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Orally Disintegrating Tablet Price by Manufacturer (2019-2021)
  • 3.4 Global Orally Disintegrating Tablet Manufacturing Base Distribution, Product Type
    • 3.4.1 Orally Disintegrating Tablet Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Orally Disintegrating Tablet Product Type
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE

  • 4.1 Global Orally Disintegrating Tablet Market Size by Type (2016-2021)
    • 4.1.1 Global Orally Disintegrating Tablet Sales by Type (2016-2021)
    • 4.1.2 Global Orally Disintegrating Tablet Revenue by Type (2016-2021)
    • 4.1.3 Orally Disintegrating Tablet Average Selling Price (ASP) by Type (2016-2021)
  • 4.2 Global Orally Disintegrating Tablet Market Size Forecast by Type (2022-2027)
    • 4.2.1 Global Orally Disintegrating Tablet Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Orally Disintegrating Tablet Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Orally Disintegrating Tablet Average Selling Price (ASP) Forecast by Type (2022-2027)

5 BREAKDOWN DATA BY APPLICATION

  • 5.1 Global Orally Disintegrating Tablet Market Size by Application (2016-2021)
    • 5.1.1 Global Orally Disintegrating Tablet Sales by Application (2016-2021)
    • 5.1.2 Global Orally Disintegrating Tablet Revenue by Application (2016-2021)
    • 5.1.3 Orally Disintegrating Tablet Price by Application (2016-2021)
  • 5.2 Orally Disintegrating Tablet Market Size Forecast by Application (2022-2027)
    • 5.2.1 Global Orally Disintegrating Tablet Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Orally Disintegrating Tablet Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Orally Disintegrating Tablet Price Forecast by Application (2022-2027)

6 NORTH AMERICA

  • 6.1 North America Orally Disintegrating Tablet Market Facts & Figures by Country
    • 6.1.1 North America Orally Disintegrating Tablet Sales by Country
    • 6.1.2 North America Orally Disintegrating Tablet Revenue by Country
    • 6.1.3 United States
    • 6.1.4 Canada
    • 6.1.5 Mexico
  • 6.2 North America Orally Disintegrating Tablet Market Facts & Figures by Type
  • 6.3 North America Orally Disintegrating Tablet Market Facts & Figures by Application

7 EUROPE

  • 7.1 Europe Orally Disintegrating Tablet Market Facts & Figures by Country
    • 7.1.1 Europe Orally Disintegrating Tablet Sales by Country
    • 7.1.2 Europe Orally Disintegrating Tablet Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Orally Disintegrating Tablet Market Facts & Figures by Type
  • 7.3 Europe Orally Disintegrating Tablet Market Facts & Figures by Application

8 ASIA PACIFIC

  • 8.1 Asia Pacific Orally Disintegrating Tablet Market Facts & Figures by Region
    • 8.1.1 Asia Pacific Orally Disintegrating Tablet Sales by Region
    • 8.1.2 Asia Pacific Orally Disintegrating Tablet Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Southeast Asia
  • 8.2 Asia Pacific Orally Disintegrating Tablet Market Facts & Figures by Type
  • 8.3 Asia Pacific Orally Disintegrating Tablet Market Facts & Figures by Application

9 SOUTH AMERICA

  • 9.1 South America Orally Disintegrating Tablet Market Facts & Figures by Country
    • 9.1.1 South America Orally Disintegrating Tablet Sales by Country
    • 9.1.2 South America Orally Disintegrating Tablet Revenue by Country
    • 9.1.3 Brazil
  • 9.2 South America Orally Disintegrating Tablet Market Facts & Figures by Type
  • 9.3 South America Orally Disintegrating Tablet Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

  • 10.1 Middle East and Africa Orally Disintegrating Tablet Market Facts & Figures by Country
    • 10.1.1 Middle East and Africa Orally Disintegrating Tablet Sales by Country
    • 10.1.2 Middle East and Africa Orally Disintegrating Tablet Sales by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 UAE
  • 10.2 Middle East and Africa Orally Disintegrating Tablet Market Facts & Figures by Type
  • 10.3 Middle East and Africa Orally Disintegrating Tablet Market Facts & Figures by Application

11 COMPANY PROFILES

  • 11.1 Teva
    • 11.1.1 Teva Corporation Information
    • 11.1.2 Teva Description and Business Overview
    • 11.1.3 Teva Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.1.4 Teva Orally Disintegrating Tablet Products Offered
    • 11.1.5 Teva Recent Developments
  • 11.2 Merck
    • 11.2.1 Merck Corporation Information
    • 11.2.2 Merck Description and Business Overview
    • 11.2.3 Merck Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.2.4 Merck Orally Disintegrating Tablet Products Offered
  • 11.3 Mylan
    • 11.3.1 Mylan Corporation Information
    • 11.3.2 Mylan Description and Business Overview
    • 11.3.3 Mylan Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.3.4 Mylan Orally Disintegrating Tablet Products Offered
    • 11.3.5 Mylan Recent Developments
  • 11.4 Pfizer
    • 11.4.1 Pfizer Corporation Information
    • 11.4.2 Pfizer Description and Business Overview
    • 11.4.3 Pfizer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.4.4 Pfizer Orally Disintegrating Tablet Products Offered
    • 11.4.5 Pfizer Recent Developments
  • 11.5 Johnson and Johnson
    • 11.5.1 Johnson and Johnson Corporation Information
    • 11.5.2 Johnson and Johnson Description and Business Overview
    • 11.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.5.4 Johnson and Johnson Orally Disintegrating Tablet Products Offered
  • 11.6 GSK
    • 11.6.1 GSK Corporation Information
    • 11.6.2 GSK Description and Business Overview
    • 11.6.3 GSK Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.6.4 GSK Orally Disintegrating Tablet Products Offered
    • 11.6.5 GSK Recent Developments
  • 11.7 Otsuka
    • 11.7.1 Otsuka Corporation Information
    • 11.7.2 Otsuka Description and Business Overview
    • 11.7.3 Otsuka Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.7.4 Otsuka Orally Disintegrating Tablet Products Offered
    • 11.7.5 Otsuka Recent Developments
  • 11.8 Eli Lilly and Company
    • 11.8.1 Eli Lilly and Company Corporation Information
    • 11.8.2 Eli Lilly and Company Description and Business Overview
    • 11.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.8.4 Eli Lilly and Company Orally Disintegrating Tablet Products Offered
    • 11.8.5 Eli Lilly and Company Recent Developments
  • 11.9 AstraZeneca
    • 11.9.1 AstraZeneca Corporation Information
    • 11.9.2 AstraZeneca Description and Business Overview
    • 11.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.9.4 AstraZeneca Orally Disintegrating Tablet Products Offered
    • 11.9.5 AstraZeneca Recent Developments
  • 11.10 Bristol-Myers Squibb
    • 11.10.1 Bristol-Myers Squibb Corporation Information
    • 11.10.2 Bristol-Myers Squibb Description and Business Overview
    • 11.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Products Offered
  • 11.11 Conquer
    • 11.11.1 Conquer Corporation Information
    • 11.11.2 Conquer Description and Business Overview
    • 11.11.3 Conquer Orally Disintegrating Tablet Sales, Revenue and Gross Margin (2019-2021)
    • 11.11.4 Conquer Orally Disintegrating Tablet Products Offered

12 MARKET FORECAST BY REGIONS (COUNTRY)

  • 12.1 Orally Disintegrating Tablet Market Estimates and Projections by Region
    • 12.1.1 Global Orally Disintegrating Tablet Sales Forecast by Region (2022-2027)
    • 12.1.2 Global Orally Disintegrating Tablet Revenue Forecast by Region (2022-2027)
  • 12.2 North America: Orally Disintegrating Tablet Market Size Forecast by Country (2022-2027)
  • 12.3 Europe: Orally Disintegrating Tablet Market Size Forecast by Country (2022-2027)
  • 12.4 Asia Pacific: Orally Disintegrating Tablet Market Size Forecast by Region (2022-2027)
  • 12.5 South America: Orally Disintegrating Tablet Market Size Forecast by Country (2022-2027)
  • 12.6 Middle East and Africa: Orally Disintegrating Tablet Market Size Forecast by Country (2022-2027)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

  • 13.1 Orally Disintegrating Tablet Market Opportunities and Drivers
  • 13.2 Orally Disintegrating Tablet Market Challenges
  • 13.3 Orally Disintegrating Tablet Market Trends
  • 13.4 Porter's Five Forces Analysis

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

  • 14.1 Orally Disintegrating Tablet Value Chain Analysis
  • 14.2 Orally Disintegrating Tablet Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details
  • 16.3 Disclaimer

List of Tables and Figures

  • Table 1. Global Orally Disintegrating Tablet Market Size Growth Rate by Type (2020-2027) & (US$ Million)
  • Table 2. Global Orally Disintegrating Tablet Market Size Growth Rate by Application (2020-2027) (M USD)
  • Table 3. Global Orally Disintegrating Tablet Market Size by Region (M Unit) & (US$ Million): 2020 VS 2027
  • Table 4. Global Orally Disintegrating Tablet Sales by Region (2016-2021) (M Unit)
  • Table 5. Global Orally Disintegrating Tablet Sales Market Share by Region (2016-2021)
  • Table 6. Global Orally Disintegrating Tablet Revenue by Region (2016-2021) (US$ Million)
  • Table 7. Global Orally Disintegrating Tablet Revenue Market Share by Region (2016-2021)
  • Table 8. Global Orally Disintegrating Tablet Sales by Manufacturer (2019-2021) (M Unit)
  • Table 9. Global Orally Disintegrating Tablet Sales Share by Manufacturer (2019-2021)
  • Table 10. Orally Disintegrating Tablet Revenue by Manufacturer (2019-2021) (US$ Million)
  • Table 11. Ranking of Global Top Orally Disintegrating Tablet Manufacturers by Revenue (US$ Million) in 2020
  • Table 12. Orally Disintegrating Tablet Revenue Share by Manufacturer (2019-2021)
  • Table 13. Global Orally Disintegrating Tablet Manufacturers Market Concentration Ratio (CR5 and HHI) (2019-2021)
  • Table 14. Global Orally Disintegrating Tablet by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orally Disintegrating Tablet as of 2020)
  • Table 15. Key Manufacturers Orally Disintegrating Tablet Price (2016-2021) (USD/Unit)
  • Table 16. Orally Disintegrating Tablet Manufacturers Manufacturing Base Distribution and Headquarters
  • Table 17. Manufacturers Orally Disintegrating Tablet Product Type
  • Table 18. Global Orally Disintegrating Tablet Sales by Type (2016-2021) (M Unit)
  • Table 19. Global Orally Disintegrating Tablet Sales Share by Type (2016-2021)
  • Table 20. Global Orally Disintegrating Tablet Revenue by Type (2016-2021) (US$ Million)
  • Table 21. Global Orally Disintegrating Tablet Revenue Share by Type (2016-2021)
  • Table 22. Orally Disintegrating Tablet Average Selling Price (ASP) by Type (2016-2021) (USD/Unit)
  • Table 23. Global Orally Disintegrating Tablet Sales Forecast by Type (2022-2027) (M Unit)
  • Table 24. Global Orally Disintegrating Tablet Sales Market Share Forecast by Type (2022-2027)
  • Table 25. Global Orally Disintegrating Tablet Revenue Forecast by Type (2022-2027) (US$ Million)
  • Table 26. Global Orally Disintegrating Tablet Revenue Market Share Forecast by Type (2022-2027)
  • Table 27. Global Orally Disintegrating Tablet Average Selling Price (ASP) Forecast by Type (2022-2027) (USD/Unit)
  • Table 28. Global Orally Disintegrating Tablet Sales by Application (2016-2021) (M Unit)
  • Table 29. Global Orally Disintegrating Tablet Sales Share by Application (2016-2021)
  • Table 30. Global Orally Disintegrating Tablet Revenue by Application (2016-2021) (US$ Million)
  • Table 31. Global Orally Disintegrating Tablet Revenue Share by Application (2016-2021)
  • Table 32. Orally Disintegrating Tablet Price by Application (2016-2021) (USD/Unit)
  • Table 33. Global Orally Disintegrating Tablet Sales Forecast by Application (2022-2027) (M Unit)
  • Table 34. Global Orally Disintegrating Tablet Sales Market Share Forecast by Application (2022-2027)
  • Table 35. Global Orally Disintegrating Tablet Revenue Forecast by Application (2022-2027) (US$ Million)
  • Table 36. Global Orally Disintegrating Tablet Revenue Market Share Forecast by Application (2022-2027)
  • Table 37. Global Orally Disintegrating Tablet Price Forecast by Application (2022-2027) (USD/Unit)
  • Table 38. North America Orally Disintegrating Tablet Sales by Country (2016-2021) (M Unit)
  • Table 39. North America Orally Disintegrating Tablet Sales Market Share by Country (2016-2021)
  • Table 40. North America Orally Disintegrating Tablet Revenue by Country (2016-2021) (US$ Million)
  • Table 41. North America Orally Disintegrating Tablet Revenue Market Share by Country (2016-2021)
  • Table 42. North America Orally Disintegrating Tablet Revenue by Type (2016-2021) (M USD)
  • Table 43. North America Orally Disintegrating Tablet Revenue Market Share by Type (2016-2021)
  • Table 44. North America Orally Disintegrating Tablet Revenue by Application (2016-2021) (M USD)
  • Table 45. North America Orally Disintegrating Tablet Revenue Market Share by Application (2016-2021)
  • Table 46. Europe Orally Disintegrating Tablet Sales by Country (2016-2021) (M Unit)
  • Table 47. Europe Orally Disintegrating Tablet Sales Market Share by Country (2016-2021)
  • Table 48. Europe Orally Disintegrating Tablet Revenue by Country (2016-2021) (US$ Million)
  • Table 49. Europe Orally Disintegrating Tablet Revenue Market Share by Country (2016-2021)
  • Table 50. Europe Orally Disintegrating Tablet Revenue by Type (2016-2021) (M USD)
  • Table 51. Europe Orally Disintegrating Tablet Revenue Market Share by Type (2016-2021)
  • Table 52. Europe Orally Disintegrating Tablet Revenue by Application (2016-2021) (M USD)
  • Table 53. Europe Orally Disintegrating Tablet Revenue Market Share by Application (2016-2021)
  • Table 54. Asia Pacific Orally Disintegrating Tablet Sales by Region (2016-2021) (M Unit)
  • Table 55. Asia Pacific Orally Disintegrating Tablet Sales Market Share by Region (2016-2021)
  • Table 56. Asia Pacific Orally Disintegrating Tablet Revenue by Region (2016-2021) (US$ Million)
  • Table 57. Asia Pacific Orally Disintegrating Tablet Revenue Market Share by Region (2016-2021)
  • Table 58. Asia Pacific Orally Disintegrating Tablet Revenue by Type (2016-2021) (M USD)
  • Table 59. Asia Pacific Orally Disintegrating Tablet Revenue Market Share by Type (2016-2021)
  • Table 60. Asia Pacific Orally Disintegrating Tablet Revenue by Application (2016-2021) (M USD)
  • Table 61. Asia Pacific Orally Disintegrating Tablet Revenue Market Share by Application (2016-2021)
  • Table 62. South America Orally Disintegrating Tablet Sales by Country (2016-2021) (M Unit)
  • Table 63. South America Orally Disintegrating Tablet Sales Market Share by Country (2016-2021)
  • Table 64. South America Orally Disintegrating Tablet Revenue by Country (2016-2021) (US$ Million)
  • Table 65. South America Orally Disintegrating Tablet Revenue Market Share by Country (2016-2021)
  • Table 66. South America Orally Disintegrating Tablet Revenue by Type (2016-2021) (M USD)
  • Table 67. South America Orally Disintegrating Tablet Revenue Market Share by Type (2016-2021)
  • Table 68. South America Orally Disintegrating Tablet Revenue by Application (2016-2021) (M USD)
  • Table 69. South America Orally Disintegrating Tablet Revenue Market Share by Application (2016-2021)
  • Table 70. Middle East and Africa Orally Disintegrating Tablet Sales by Country (2016-2021) (M Unit)
  • Table 71. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Country (2016-2021)
  • Table 72. Middle East and Africa Orally Disintegrating Tablet Sales by Country (2016-2021) (US$ Million)
  • Table 73. Middle East and Africa Orally Disintegrating Tablet Revenue Market Share by Country (2016-2021)
  • Table 74. Middle East and Africa Orally Disintegrating Tablet Revenue by Type (2016-2021) (M USD)
  • Table 75. Middle East and Africa Orally Disintegrating Tablet Revenue by Application (2016-2021) (M USD)
  • Table 76. Middle East and Africa Orally Disintegrating Tablet Revenue Market Share by Application (2016-2021)
  • Table 77. Teva Corporation Information
  • Table 78. Teva Description and Business Overview
  • Table 79. Teva Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 80. Teva Recent Developments
  • Table 81. Merck Corporation Information
  • Table 82. Merck Description and Business Overview
  • Table 83. Merck Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 84. Mylan Corporation Information
  • Table 85. Mylan Description and Business Overview
  • Table 86. Mylan Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 87. Mylan Recent Developments
  • Table 88. Pfizer Corporation Information
  • Table 89. Pfizer Description and Business Overview
  • Table 90. Pfizer Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 91. Pfizer Recent Developments
  • Table 92. Johnson and Johnson Corporation Information
  • Table 93. Johnson and Johnson Description and Business Overview
  • Table 94. Johnson and Johnson Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 95. GSK Corporation Information
  • Table 96. GSK Description and Business Overview
  • Table 97. GSK Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 98. GSK Recent Developments
  • Table 99. Otsuka Corporation Information
  • Table 100. Otsuka Description and Business Overview
  • Table 101. Otsuka Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 102. Otsuka Recent Developments
  • Table 103. Eli Lilly and Company Corporation Information
  • Table 104. Eli Lilly and Company Description and Business Overview
  • Table 105. Eli Lilly and Company Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 106. Eli Lilly and Company Recent Developments
  • Table 107. AstraZeneca Corporation Information
  • Table 108. AstraZeneca Description and Business Overview
  • Table 109. AstraZeneca Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 110. AstraZeneca Recent Developments
  • Table 111. Bristol-Myers Squibb Corporation Information
  • Table 112. Bristol-Myers Squibb Description and Business Overview
  • Table 113. Bristol-Myers Squibb Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 114. Conquer Corporation Information
  • Table 115. Conquer Description and Business Overview
  • Table 116. Conquer Orally Disintegrating Tablet Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 117. Global Orally Disintegrating Tablet Sales Forecast by Region (2022-2027) (M Unit)
  • Table 118. Global Orally Disintegrating Tablet Sales Market Share Forecast by Region (2022-2027)
  • Table 119. Global Orally Disintegrating Tablet Revenue Forecast by Region (2022-2027) (US$ Million)
  • Table 120. Global Orally Disintegrating Tablet Revenue Market Share Forecast by Region (2022-2027)
  • Table 121. North America: Orally Disintegrating Tablet Sales Forecast by Country (2022-2027) (M Unit)
  • Table 122. North America: Orally Disintegrating Tablet Revenue Forecast by Country (2022-2027) (US$ Million)
  • Table 123. Europe: Orally Disintegrating Tablet Sales Forecast by Country (2022-2027) (M Unit)
  • Table 124. Europe: Orally Disintegrating Tablet Revenue Forecast by Country (2022-2027) (US$ Million)
  • Table 125. Asia Pacific: Orally Disintegrating Tablet Sales Forecast by Region (2022-2027) (M Unit)
  • Table 126. Asia Pacific: Orally Disintegrating Tablet Revenue Forecast by Region (2022-2027) (US$ Million)
  • Table 127. South America: Orally Disintegrating Tablet Sales Forecast by Country (2022-2027) (M Unit)
  • Table 128. South America: Orally Disintegrating Tablet Revenue Forecast by Country (2022-2027) (US$ Million)
  • Table 129. Middle East and Africa: Orally Disintegrating Tablet Sales Forecast by Country (2022-2027) (M Unit)
  • Table 130. Middle East and Africa: Orally Disintegrating Tablet Revenue Forecast by Country (2022-2027) (US$ Million)
  • Table 131. Orally Disintegrating Tablet Market Opportunities and Drivers
  • Table 132. Orally Disintegrating Tablet Market Challenges
  • Table 133. Orally Disintegrating Tablet Market Trends
  • Table 134. Orally Disintegrating Tablet Customers List
  • Table 135. Orally Disintegrating Tablet Distributors List
  • Table 136. Research Programs/Design for This Report
  • Table 137. Key Data Information from Secondary Sources
  • Table 138. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Orally Disintegrating Tablet Product Picture
  • Figure 2. Global Orally Disintegrating Tablet Sales Market Share by Type in 2020
  • Figure 3. Global Orally Disintegrating Tablet Sales Market Share by Type in 2027
  • Figure 4. Anti-Psychotics Drug Product Picture
  • Figure 5. Anti-Epileptics Drug Product Picture
  • Figure 6. Global Orally Disintegrating Tablet Sales Market Share by Application in 2020
  • Figure 7. Global Orally Disintegrating Tablet Sales Market Share by Application in 2027
  • Figure 8. CNS Diseases
  • Figure 9. Gastrointestinal Diseases
  • Figure 10. CVS Diseases
  • Figure 11. Orally Disintegrating Tablet Report Years Considered
  • Figure 12. Global Orally Disintegrating Tablet Market Size (Value), (US$ Million), 2015 VS 2020 VS 2027
  • Figure 13. Global Orally Disintegrating Tablet Market Size 2016-2027 (US$ Million)
  • Figure 14. Global Orally Disintegrating Tablet Sales 2016-2027 (M Unit)
  • Figure 15. Global Orally Disintegrating Tablet Market Size Market Share by Region: 2016 VS 2020 Versus 2027
  • Figure 16. Global Orally Disintegrating Tablet Sales Market Share by Region (2016-2021)
  • Figure 17. Global Orally Disintegrating Tablet Sales Market Share by Region in 2020
  • Figure 18. Global Orally Disintegrating Tablet Revenue Market Share by Region in 2020
  • Figure 19. Global Orally Disintegrating Tablet Sales Share by Manufacturer in 2020
  • Figure 20. The Top 6 Players Market Share by Orally Disintegrating Tablet Revenue in 2020
  • Figure 21. Global Orally Disintegrating Tablet Sales Market Share by Type (2016-2021)
  • Figure 22. Global Orally Disintegrating Tablet Sales Market Share by Type in 2020
  • Figure 23. Global Orally Disintegrating Tablet Revenue Market Share by Type (2016-2021)
  • Figure 24. Global Orally Disintegrating Tablet Revenue Market Share by Type in 2020
  • Figure 25. Global Orally Disintegrating Tablet Sales Market Share by Application (2016-2021)
  • Figure 26. Global Orally Disintegrating Tablet Sales Market Share by Application in 2020
  • Figure 27. Global Orally Disintegrating Tablet Revenue Market Share by Application (2016-2021)
  • Figure 28. Global Orally Disintegrating Tablet Revenue Market Share by Application in 2020
  • Figure 29. North America Orally Disintegrating Tablet Sales Market Share by Country in 2020
  • Figure 30. North America Orally Disintegrating Tablet Revenue Market Share by Country in 2020
  • Figure 31. United States Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 32. Canada Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 33. Mexico Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 34. North America Orally Disintegrating Tablet Market Share by Application in 2019
  • Figure 35. Europe Orally Disintegrating Tablet Revenue Market Share by Country in 2020
  • Figure 36. Germany Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 37. France Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 38. U.K. Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 39. Italy Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 40. Russia Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 41. Europe Orally Disintegrating Tablet Market Share by Type in 2020
  • Figure 42. China Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 43. Japan Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 44. South Korea Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 45. India Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 46. Australia Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 47. Southeast Asia Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 48. Brazil Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 49. Middle East and Africa Orally Disintegrating Tablet Revenue Market Share by Country in 2020
  • Figure 50. Turkey Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 51. Saudi Arabia Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 52. UAE Orally Disintegrating Tablet Revenue Growth Rate (2016-2021) (US$ Million)
  • Figure 53. Middle East and Africa Orally Disintegrating Tablet Market Share by Type in 2020
  • Figure 54. Teva Orally Disintegrating Tablet Product
  • Figure 55. Merck Orally Disintegrating Tablet Product
  • Figure 56. Mylan Orally Disintegrating Tablet Product
  • Figure 57. Pfizer Orally Disintegrating Tablet Product
  • Figure 58. Johnson and Johnson Orally Disintegrating Tablet Product
  • Figure 59. GSK Orally Disintegrating Tablet Product
  • Figure 60. Otsuka Orally Disintegrating Tablet Product
  • Figure 61. Eli Lilly and Company Orally Disintegrating Tablet Product
  • Figure 62. AstraZeneca Orally Disintegrating Tablet Product
  • Figure 63. Bristol-Myers Squibb Orally Disintegrating Tablet Product
  • Figure 64. Conquer Orally Disintegrating Tablet Product
  • Figure 65. Porter's Five Forces Analysis
  • Figure 66. Orally Disintegrating Tablet Value Chain
  • Figure 67. Channels of Distribution
  • Figure 68. Distributors Profiles
  • Figure 69. Bottom-up and Top-down Approaches for This Report
  • Figure 70. Data Triangulation
  • Figure 71. Key Executives Interviewed 116
Back to Top